Simon Joel

Kinase-Substrate Enrichment Analysis Provides Insights into the Heterogeneity of Signaling Pathway Activation in Leukemia Cells

Pedro Casado, Juan‐Carlos Rodríguez‐Prados, Sabina Cosulich et al. · Science Signaling · 2013 · 470 citations

Life Sciences, Cell Biology, Oncology +11

Morphine and metabolite behavior after different routes of morphine administration: Demonstration of the importance of the active metabolite morphine-6-glucuronide

Richard H. Osborne, Simon Joel, Duncan Trew et al. · Clinical Pharmacology & Therapeutics · 1990 · 448 citations

Medicine, Pharmacokinetics, Pharmacology +15

The pharmacokinetics of morphine and morphine glucuronides in kidney failure

Richard H. Osborne, Simon Joel, Kate Grebenik et al. · Clinical Pharmacology & Therapeutics · 1993 · 210 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

GCS-100, a novel galectin-3 antagonist, modulates MCL-1, NOXA, and cell cycle to induce myeloma cell death

Matthew Streetly, Lenushka Maharaj, Simon Joel et al. · Blood · 2010 · 132 citations · Full text

Medicine, Cell Biology, Oncology +16

P110α-mediated constitutive PI3K signaling limits the efficacy of p110δ-selective inhibition in mantle cell lymphoma, particularly with multiple relapse

Sunil Iyengar, Andrew Clear, Csaba Bödör et al. · Blood · 2013 · 126 citations · Full text

Medicine, Cancer Biology, Oncology +15